Acer Therapeutics Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q1 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Acer Therapeutics Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q1 2021 to Q3 2023.
  • Acer Therapeutics Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending September 30, 2023 was $372K.
  • Acer Therapeutics Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $1.26M.
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $372K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q1 2021 $900K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.